Try our beta test site
40 studies found for:    Open Studies | "Urticaria"
Show Display Options
Rank Status Study
21 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
22 Recruiting Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Conditions: Allergic Cutaneous Vasculitis;   Urticaria;   Psoriasis;   Acne;   Bullous Skin Diseases;   Sterile Pustulosis;   Leprosy;   Pneumocystis Pneumonia
Intervention: Drug: Dapsone
23 Recruiting Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Conditions: Cryoglobulinemic Vasculitis (CV);   Drug-induced Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis (EGPA);   IgA Vasculitis;   Isolated Cutaneous Vasculitis;   Granulomatosis With Polyangiitis (GPA);   Microscopic Polyangiitis (MPA);   Polyarteritis Nodosa (PAN);   Urticarial Vasculitis;   Vasculitis
Intervention:
24 Recruiting Vasculitis Pregnancy Registry
Conditions: Vasculitis;   Behcet's Disease;   CNS Vasculitis;   Cryoglobulinemic Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis (EGPA);   Churg-Strauss Syndrome (CSS);   Granulomatosis With Polyangiitis (GPA);   Wegener's Granulomatosis;   IgA Vasculitis;   Henoch-Schoenlein Purpura (HSP);   Microscopic Polyangiitis (MPA);   Polyarteritis Nodosa (PAN);   Takayasu Arteritis (TAK);   Urticarial Vasculitis;   Systemic Vasculitis
Intervention: Other: Online questionnaires
25 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
Intervention:
26 Not yet recruiting Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy
Condition: Idiopathic Angioedema
Interventions: Drug: Omalizumab;   Drug: Placebos
27 Recruiting Determination of Specific Biomarkers of Angioneurotic Crisis
Condition: Angioedema
Intervention:
28 Recruiting Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema
Condition: Acute ACE-induced Angioedema
Interventions: Drug: Berinert;   Drug: Clemastin;   Drug: Cortisone acetate;   Drug: NaCl
29 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
30 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
31 Recruiting Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: BCX7353;   Drug: Placebo
32 Recruiting Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: CINRYZE 500 U;   Drug: CINRYZE 1000 U
33 Recruiting Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population
Conditions: Hereditary Angioedema;   Healthy Volunteers
Intervention: Other: blood sample
34 Recruiting Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Intervention: Drug: Ecallantide subcutaneous dosing
35 Recruiting C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
36 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
37 Recruiting Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Condition: Hereditary Angioedema (HAE)
Intervention:
38 Not yet recruiting Biomarker for Hereditary Angioedema Disease Type 1
Conditions: Hereditary AngioEdema;   Angioedema, Hereditary;   Angio-Oedema of Lips;   Angio-Oedema of Tongue
Intervention:
39 Recruiting Mast Cell Connect: A Registry for Patients With Mastocytosis
Condition: Mastocytosis
Intervention:
40 Recruiting Cause of Unexplained Anaphylaxis
Condition: Anaphylaxis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Study has passed its completion date and status has not been verified in more than two years.